表紙
市場調查報告書

人類生殖技術的全球市場:各技術,各地區的市場規模,佔有率,展望,機會分析:2020年-2027年

Human Reproductive Technologies Market, By Technology, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 948360
出版日期 內容資訊 英文 181 Pages
商品交期: 2-3個工作天內
價格
人類生殖技術的全球市場:各技術,各地區的市場規模,佔有率,展望,機會分析:2020年-2027年 Human Reproductive Technologies Market, By Technology, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年06月17日內容資訊: 英文 181 Pages
簡介

人的生殖技術,對應妊娠和不孕的問題,包含輔助的生殖技術(ART)、預後、避孕、同性生殖等。ART,採用人工授精,人工生殖,基因複製,細胞質移植,不孕治療,荷爾蒙治療等,是支援低妊娠和不孕的治療技術。

本報告提供全球人類生殖技術市場調查,與市場力學和法規,趨勢分析,各技術,各地區的分析,競爭情形企業簡介等資訊。

目錄

第1章 調查的目的與前提

第2章 市場展望

    • 報告概要
    • 市場定義和範圍
    • 摘要整理
    • 各技術
    • 市場機會藍圖

第3章 市場力學,法規,趨勢分析

    • 市場力學
    • 成長促進因素
    • 成長阻礙因素
    • 市場機會
    • 影響分析
    • 主要的動向
    • 技術的進步
    • 法規方案

第4章 市場分析:各技術

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長率分析
  • 市場區隔趨勢
    • 不孕症藥物
    • 避孕藥和避孕器

第5章 市場分析:各地區

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長率分析
  • 市場區隔趨勢
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韓國
      • 其他
    • 南美
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他
    • 中東
      • GCC
      • 以色列
      • 其他
    • 非洲
      • 北非
      • 中非
      • 南非

第6章 競爭情形

    • 企業簡介
    • Abbott Laboratories
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • Evofem Biosciences,Inc.
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • Actavis Generics(Teva Pharmaceutical Industries Ltd.)
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • Sun Pharmaceutical Industries Ltd.
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • Perrigo Company plc
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • Uniprix
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • Gavis Pharmaceuticals(Lupin Limited)
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • Sandoz International GmbH
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • Aurobindo Pharma Limited
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • HRA Pharma,SA
    • 公司概要
    • 產品系列
    • 主要的發展
    • 財務成果
    • 策略
    • 其他的主要企業

第7章

  • 參考文件
  • 調查手法
目錄

Title:
Human Reproductive Technologies Market, By Technology (Infertility Drugs, Contraceptive Drugs and Devices), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Human reproductive technologies assist parents who are having troubles in pregnancies, and infertility issues. These technologies include Assisted Reproductive Technology (ART), prognostics, contraception, and same-sex procreation. ART aids in the treatment of low fertility or infertility using artificial insemination, artificial reproduction, cloning, cytoplasmic transfer, fertility medication, hormone treatment, and others.

Restraints of the Global Human Reproductive Technologies Market

Major factors hampering the growth of the human reproductive technologies market during the forecast period constitutes of limited insurance coverage for ART, and low adoption of emergency human reproductive technologies in emerging economies.

Key features of the study:

  • This report provides in-depth analysis of the global human reproductive technologies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global human reproductive technologies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Evofem Biosciences, Inc., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Uniprix, Gavis Pharmaceuticals (Lupin Limited), Sandoz International GmbH, Aurobindo Pharma Limited, HRA Pharma, SA, Mankind Pharma, Cryos USA, Merck & Co, Bayer HealthCare AG, Church & Dwight, Co. Inc., Allergan, Pfizer, Inc., Agile Therapeutics Inc., BioSante Pharmaceuticals Inc., Mayer Laboratories, Inc., Pantarhei Bioscience B.V., Cook Medical, Inc., Ferring Pharmaceuticals, Johnson & Johnson, Dare Bioscience, Inc., and Merck Serono.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global human reproductive technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Human Reproductive Technologies Market, By Technology:
    • Infertility Drugs
    • Contraceptive Drugs and Devices
  • Global Human Reproductive Technologies Market, By Geography:
    • North America
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • U.S.
  • Canada
    • Europe
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
    • Asia Pacific
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
    • Latin America
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • Middle East:
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • Africa
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
    • Abbott Laboratories*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
    • Evofem Biosciences, Inc.
    • Actavis Generics (Teva Pharmaceutical Industries Ltd.)
    • Sun Pharmaceutical Industries Ltd.
    • Perrigo Company plc
    • Uniprix
    • Gavis Pharmaceuticals (Lupin Limited)
    • Sandoz International GmbH
    • Aurobindo Pharma Limited
    • HRA Pharma, SA
    • Other Major Players

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Technology
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario

4. Global Human Reproductive Technologies Market, By Technology, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Infertility Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Contraceptive Drugs and Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends

5. Global Human Reproductive Technologies Market, By Regions, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

    • Company Profiles
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Evofem Biosciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Actavis Generics (Teva Pharmaceutical Industries Ltd.)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Perrigo Company plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Uniprix
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Gavis Pharmaceuticals (Lupin Limited)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Sandoz International GmbH
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Aurobindo Pharma Limited
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • HRA Pharma, SA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Other Major Players
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

7. Section

    • References
    • Research Methodology
    • About us and Sales Contact